Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2534 ARTíCULOS , VIENDO DEL 2506 AL 2520

PUBMED

Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.

Mielke MM, Maetzler W, Haughey NJ, Bandaru VV, Savica R, Deuschle C, Gasser T, Hauser AK, Gräber-Sultan S, Schleicher E, Berg D, Liepelt-Scarfone I.

PLoS One. 2013 Sep 18;8(9):e73094. doi: 10.1371/journal.pone.0073094.

0

0

0

PUBMED

Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease.

Müller B, Assmus J, Larsen JP, Haugarvoll K, Skeie GO, Tysnes OB; ParkWest study group..

Acta Neurol Scand. 2013 Apr;127(4):290-4. doi: 10.1111/ane.12010.

0

0

0

PUBMED

The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.

Sławek J, Roszmann A, Robowski P, Dubaniewicz M, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Kurzawski M, Bandurski T, Białecka M.

Neurodegener Dis. 2013;12(1):1-12. doi: 10.1159/000338610.

0

0

0

PUBMED

Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's disease.

Fleury V, Wider C, Horvath J, Zacharia A, Bally J, Pollak P, Pollo C, Vingerhoets FJ, Burkhard PR.

Parkinsonism Relat Disord. 2013 Jul;19(7):707-8. doi: 10.1016/j.parkreldis.2013.04.002. No abstract available.

0

0

0

PUBMED

Illness beliefs and psychological outcome in people with Parkinson's disease.

Simpson J, Lekwuwa G, Crawford T.

Chronic Illn. 2013 Jun;9(2):165-76. doi: 10.1177/1742395313478219.

0

0

0

PUBMED

Association between head injury and Parkinson's disease: an observation in Taiwan.

Lai SW, Liao KF, Lin CL, Sung FC.

Geriatr Gerontol Int. 2013 Apr;13(2):513-4. doi: 10.1111/j.1447-0594.2012.00960.x. No abstract available.

0

0

0

PUBMED

[JSN treatment guideline for Parkinson's disease: its editorial policy and problems to be addressed].

Takahashi R.

Rinsho Shinkeigaku. 2013;53(11):1343-5. Japanese.

0

0

0

PUBMED

Supplementary motor area stimulation for Parkinson disease: a randomized controlled study.

Shirota Y, Ohtsu H, Hamada M, Enomoto H, Ugawa Y; Research Committee on rTMS Treatment of Parkinson's Disease..

Neurology. 2013 Apr 9;80(15):1400-5. doi: 10.1212/WNL.0b013e31828c2f66.

0

0

0

PUBMED

Methylphenidate : a treatment for Parkinson's disease?

Devos D, Moreau C, Delval A, Dujardin K, Defebvre L, Bordet R.

CNS Drugs. 2013 Jan;27(1):1-14. doi: 10.1007/s40263-012-0017-y.

0

0

0

PUBMED

Parkinson's disease and α-synuclein: passing it on.

Skaper SD.

CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):2. No abstract available.

0

0

0

PUBMED

α-Synuclein and mitochondrial dysfunction in Parkinson's disease.

Mullin S, Schapira A.

Mol Neurobiol. 2013 Apr;47(2):587-97. doi: 10.1007/s12035-013-8394-x. Review.

0

0

0

PUBMED

Parkinson's disease: how is employment affected?

Murphy R, Tubridy N, Kevelighan H, O'Riordan S.

Ir J Med Sci. 2013 Sep;182(3):415-9. doi: 10.1007/s11845-013-0902-5.

0

0

0

PUBMED

Obstacle Avoidance amongst Parkinson Disease Patients Is Challenged in a Threatening Context.

Doan JB, de Bruin N, Pellis SM, Suchowersky O, Whishaw IQ, Brown LA.

J Neurodegener Dis. 2013;2013:787861. doi: 10.1155/2013/787861.

0

0

0

PUBMED

Somatosensory temporal discrimination threshold may help to differentiate patients with multiple system atrophy from patients with Parkinson's disease.

Rocchi L, Conte A, Nardella A, Li Voti P, Di Biasio F, Leodori G, Fabbrini G, Berardelli A.

Eur J Neurol. 2013 Apr;20(4):714-9. doi: 10.1111/ene.12059.

0

0

0

PUBMED

Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Guerrero E, Vasudevaraju P, Hegde ML, Britton GB, Rao KS.

Mol Neurobiol. 2013 Apr;47(2):525-36. doi: 10.1007/s12035-012-8328-z. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy